Comments on: Improper Marketing As An Infectious Disease: Pfizer Probe Looks At CME Payments http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/ News, Comment and Conversation Sun, 21 Mar 2010 23:26:15 +0000 http://wordpress.org/?v=2.6.2 By: CA MD http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-16468 CA MD Tue, 07 Aug 2007 16:27:45 +0000 http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-16468 Big Pharma Marketing controlling CME content and speakers as well as abusing unrestricted educational grants for their own gain are nothing new. Virtually all are guilty in some way, yet it keeps happening over and over again, Corporate Integrity Agreement or not. Big Pharma Marketing controlling CME content and speakers as well as abusing unrestricted educational grants for their own gain are nothing new. Virtually all are guilty in some way, yet it keeps happening over and over again, Corporate Integrity Agreement or not.

]]> By: John Mack http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14962 John Mack Mon, 09 Jul 2007 11:48:57 +0000 http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14962 Ed, This week -- July 10 to be precise! -- the Pharma Marketing Talk podcast features an interview with an interview of Daniel Carlat, a professor at Tufts Medical School and editor in chief of The Carlat Psychiatry Report, who characterized pharma-sponsored Continuing Medical education (CME) as "a new twist on that well-known instrument of corruption, money laundering." Your readers can get more information about listening in as well as submitting comments or questions by joining the discussion in the Pharma Marketing Events Forum (<a HREf="http://www.forums.pharma-mkting.com/showthread.php?t=774" rel="nofollow">click here</A>). Ed,

This week — July 10 to be precise! — the Pharma Marketing Talk podcast features an interview with an interview of Daniel Carlat, a professor at Tufts Medical School and editor in chief of The Carlat Psychiatry Report, who characterized pharma-sponsored Continuing Medical education (CME) as “a new twist on that well-known instrument of corruption, money laundering.”

Your readers can get more information about listening in as well as submitting comments or questions by joining the discussion in the Pharma Marketing Events Forum (click here).

]]> By: eDrugSearch Blog » Blog Archive » CME = Compensate ME! http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14871 eDrugSearch Blog » Blog Archive » CME = Compensate ME! Sun, 08 Jul 2007 13:53:24 +0000 http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14871 [...] ME! Ed Silverman at Pharmalot recently wrote a great post on the ethical challenges inherent in Continuing Medical Education (CME) programs. He says CME lies at the delicate intersection where drugmakers, doctors and money all [...] [...] ME! Ed Silverman at Pharmalot recently wrote a great post on the ethical challenges inherent in Continuing Medical Education (CME) programs. He says CME lies at the delicate intersection where drugmakers, doctors and money all [...]

]]> By: Lisa Van Syckel http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14471 Lisa Van Syckel Thu, 28 Jun 2007 16:48:38 +0000 http://www.pharmalot.com/2007/06/improper-marketing-as-an-infectious-disease-pfizer-probe-looks-at-cme-payments/#comment-14471 This was GREAT Lunch time reading...... This was GREAT Lunch time reading……

]]>